Trial Profile
The Association of Breast Density Changes, Plasma Hormone Changes, and Breast Cancer Recurrence: A Companion Study to NCIC CTG MA.27
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Exemestane (Primary) ; Anastrozole; Celecoxib
- Indications Early breast cancer
- Focus Therapeutic Use
- 22 Jan 2019 Status changed from active, no longer recruiting to completed.
- 23 Mar 2016 New trial record